Exagen, Inc. (XGN)
4.13
-0.28
(-6.35%)
USD |
NASDAQ |
Nov 13, 16:00
4.125
0.00 (0.00%)
After-Hours: 19:59
Exagen Price to Book Value : 7.622 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 7.622 |
| November 12, 2026 | 8.138 |
| November 11, 2026 | 9.292 |
| November 10, 2026 | 9.707 |
| November 09, 2026 | 13.10 |
| November 06, 2026 | 10.72 |
| November 05, 2026 | 14.02 |
| November 04, 2026 | 15.70 |
| November 03, 2026 | 15.39 |
| November 02, 2026 | 15.48 |
| October 30, 2026 | 15.85 |
| October 29, 2026 | 16.05 |
| October 28, 2026 | 15.50 |
| October 27, 2026 | 14.36 |
| October 26, 2026 | 13.79 |
| October 23, 2026 | 13.42 |
| October 22, 2026 | 13.80 |
| October 21, 2026 | 14.54 |
| October 20, 2026 | 13.67 |
| October 19, 2026 | 13.71 |
| October 16, 2026 | 14.25 |
| October 15, 2026 | 15.80 |
| October 14, 2026 | 15.54 |
| October 13, 2026 | 15.65 |
| October 12, 2026 | 15.22 |
| Date | Value |
|---|---|
| October 09, 2026 | 15.54 |
| October 08, 2026 | 15.08 |
| October 07, 2026 | 15.32 |
| October 06, 2026 | 15.11 |
| October 05, 2026 | 15.61 |
| October 02, 2026 | 15.08 |
| October 01, 2026 | 14.56 |
| September 30, 2026 | 15.00 |
| September 29, 2026 | 16.44 |
| September 28, 2026 | 16.79 |
| September 25, 2026 | 17.27 |
| September 24, 2026 | 17.31 |
| September 23, 2026 | 16.93 |
| September 22, 2026 | 17.31 |
| September 21, 2026 | 17.07 |
| September 18, 2026 | 16.66 |
| September 17, 2026 | 15.59 |
| September 16, 2026 | 15.41 |
| September 15, 2026 | 14.83 |
| September 14, 2026 | 14.56 |
| September 11, 2026 | 13.92 |
| September 10, 2026 | 13.80 |
| September 09, 2026 | 14.48 |
| September 08, 2026 | 14.46 |
| September 04, 2026 | 15.01 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Myriad Genetics, Inc. | 2.014 |
| BioRestorative Therapies, Inc. | 0.6274 |
| CareDx, Inc. | 8.740 |
| Natera, Inc. | 24.64 |
| Sera Prognostics, Inc. | 1.523 |
Price to Book Value Related Metrics
| PS Ratio | 1.377 |
| Price | 4.13 |
| Earnings Yield | -18.20% |
| Market Cap | 104.99M |